4.5 Article

Development of an updated, standardized, patient-centered outcome set for lung cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biology

Next Generation Sequencing Technology in Lung Cancer Diagnosis

Calin Cainap et al.

Summary: Lung cancer remains one of the most commonly diagnosed and deadly cancers in the world. Early diagnosis is crucial for improving the standard of care. Next generation sequencing has been proven as a helpful tool in early cancer detection, including lung cancer, due to its advantages of low cost, speed, efficacy, low sample usage, and diversity.

BIOLOGY-BASEL (2021)

Article Oncology

Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study

Evalien Veldhuijzen et al.

Summary: A subset of PRO-CTCAE items relevant to patients with lung cancer was developed through a mixed methods approach, involving a literature review and semistructured interviews with both patients and healthcare practitioners. A final list of eight clinically relevant items was identified for use in monitoring lung cancer patients in clinical practice settings. Further validation and testing of this subset internationally and in real-world clinical practice is needed for confirmation of its effectiveness.

JMIR CANCER (2021)

Article Oncology

A core set of patient-reported outcomes for population-based cancer survivorship research: a consensus study

Imogen Ramsey et al.

Summary: This study aimed to establish a core set of patient-reported outcomes (PROs) for cancer survivors, identifying twelve outcome domains deemed most important for assessing long-term health, functioning, and quality of life. The adoption of this core outcome set will ensure that these critical survivorship outcomes are consistently measured in future population-based research, enhancing the quality and comparability of data provided by cancer survivors.

JOURNAL OF CANCER SURVIVORSHIP (2021)

Article Oncology

Cancer statistics for the year 2020: An overview

Jacques Ferlay et al.

Summary: The study briefly reviews the methods and data sources used in compiling the IARC GLOBOCAN cancer statistics for 2020 and summarizes the main results. It estimated that there were nearly 19.3 million new cancer cases and almost 10 million cancer deaths worldwide in 2020, with the most commonly diagnosed cancers being female breast cancer and lung cancer, and the most common causes of cancer death being lung cancer and liver cancer.

INTERNATIONAL JOURNAL OF CANCER (2021)

Review Oncology

Efficacy and Safety of First-Line Immunotherapy Combinations for Advanced NSCLC: A Systematic Review and Network Meta-Analysis

Lihui Liu et al.

Summary: This study found that anti-PD-1 combinations may be associated with higher survival outcomes than anti-PD-L1 combinations in patients with advanced NSCLC. Pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy appear to be superior first-line immunotherapy combinations. (Word count: 104)

JOURNAL OF THORACIC ONCOLOGY (2021)

Review Oncology

Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis

Fabio Conforti et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

Article Multidisciplinary Sciences

Sex and survival in non-small cell lung cancer: A nationwide cohort study

Cecilia Radkiewicz et al.

PLOS ONE (2019)

Review Oncology

The role of immunotherapy in small cell lung cancer

A. Calles et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2019)

Article Health Care Sciences & Services

Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire

Marieke Van Leeuwen et al.

HEALTH AND QUALITY OF LIFE OUTCOMES (2018)

Review Medicine, Research & Experimental

The COMET Handbook: version 1.0

Paula R. Williamson et al.

TRIALS (2017)

Article Respiratory System

Defining a standard set of patient-centred outcomes for lung cancer

Kimberley S. Mak et al.

EUROPEAN RESPIRATORY JOURNAL (2016)

Review Oncology

Scientific Advances in Lung Cancer 2015

Anne S. Tsao et al.

JOURNAL OF THORACIC ONCOLOGY (2016)

Review Medicine, General & Internal

A scoping review of rapid review methods

Andrea C. Tricco et al.

BMC MEDICINE (2015)

Editorial Material Medicine, Research & Experimental

Developing core outcome sets for clinical trials: issues to consider

Paula R. Williamson et al.

TRIALS (2012)

Article Health Care Sciences & Services

GRADE guidelines: 2. Framing the question and deciding on important outcomes

Gordon H. Guyatt et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)